Ae. Ottenhoffkalff et al., PROTEIN-TYROSINE-PHOSPHATASE ACTIVITY AS A DIAGNOSTIC PARAMETER IN BREAST-CANCER, Breast cancer research and treatment, 33(3), 1995, pp. 245-256
Cellular phosphotyrosine levels are regulated by the balance between p
rotein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs
). It is supposed that this balance is disturbed in tumour cells, maki
ng the increased or altered activity of PTKs and PTPs likely hallmarks
of tumour tissues. Indeed it could be shown that the PTK activity was
increased in breast cancer in correlation with prognosis (Hennipman e
r al, Cancer Res. 49, 516-522, 1989). In the present report we measure
d the PTP activities in breast cancer and normal breast tissues. An in
crease of approximately three- to four-fold was measured in the cytoso
lic tumour fractions compared to normal, whereas the solubilized membr
ane fraction PTP activity showed an increase in tumours of approximate
ly 1.5-fold. Remarkably, the membrane PTP activity correlated with the
presence of tumour positive axillary lymph nodes (p = 0.004), whereas
the cytosolic PTP activity correlated with the mitotic index, a highe
r PTP activity occurring when the mitotic index was higher than 10 (p
= 0.0004). These results indicate that membrane PTP activity may be co
nsidered as an index of metastatic potential, whereas cytosolic PTP ac
tivity may be a measure of the growth capacity of the tumour. The incr
ease of PTP activity in breast cancers was confirmed by enzyme-histoch
emical studies. In frozen sections of tumours a strong to moderate act
ivity was found in both tumour cells and interstitial cells. In the in
terstitium membrane activity was most pronounced, whereas in the tumou
r cells diffuse staining of the cytoplasm together with a clear membra
ne staining was demonstrated. Immunoblotting with anti-phosphotyrosine
antibodies also reveals differences between the tumours and normal ti
ssues, confirming the disturbance of the balance between protein tyros
yl phosphorylation and dephosphorylation in the tumour cells.